$RMD
RESMED INC

2022 Q4 Form 10-Q Financial Statement

#000094381922000019 Filed on October 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $1.034B $950.3M $904.0M
YoY Change 15.52% 5.12% 20.22%
Cost Of Revenue $454.0M $409.5M $397.7M
YoY Change 16.25% 2.96% 26.95%
Gross Profit $579.7M $540.8M $506.3M
YoY Change 14.95% 6.82% 15.42%
Gross Profit Margin 56.08% 56.91% 56.0%
Selling, General & Admin $211.7M $193.9M $176.7M
YoY Change 14.19% 9.74% 11.15%
% of Gross Profit 36.51% 35.86% 34.9%
Research & Development $69.87M $63.19M $59.95M
YoY Change 11.79% 5.4% 9.93%
% of Gross Profit 12.05% 11.68% 11.84%
Depreciation & Amortization $37.77M $36.27M $39.10M
YoY Change -7.41% -7.23% -0.92%
% of Gross Profit 6.51% 6.71% 7.72%
Operating Expenses $299.5M $265.1M $244.4M
YoY Change 17.18% 8.47% 10.2%
Operating Profit $280.2M $275.7M $261.9M
YoY Change 12.66% 5.28% 20.76%
Interest Expense -$4.796M -$12.44M $5.360M
YoY Change -180.63% -332.13% -20.3%
% of Operating Profit -1.71% -4.51% 2.05%
Other Income/Expense, Net -$6.503M -$13.95M -$3.125M
YoY Change -43.08% 346.27% 199.9%
Pretax Income $273.7M $261.8M $258.8M
YoY Change 15.34% 1.16% 19.89%
Income Tax $48.78M $51.32M $55.18M
% Of Pretax Income 17.82% 19.6% 21.32%
Net Earnings $224.9M $210.5M $203.6M
YoY Change 11.48% 3.37% 14.15%
Net Earnings / Revenue 21.76% 22.15% 22.52%
Basic Earnings Per Share $1.53 $1.44 $1.40
Diluted Earnings Per Share $1.53 $1.43 $1.39
COMMON SHARES
Basic Shares Outstanding 146.5M shares 146.4M shares 145.7M
Diluted Shares Outstanding 147.4M shares 147.1M shares 146.9M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $253.2M $207.2M $276.1M
YoY Change 30.2% -24.98% -34.47%
Cash & Equivalents $253.2M $207.2M $276.1M
Short-Term Investments
Other Short-Term Assets $147.4M $126.1M $202.1M
YoY Change -29.76% -37.59% 19.8%
Inventory $989.0M $864.9M $506.6M
Prepaid Expenses
Receivables $672.3M $620.5M $575.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.325B $2.034B $1.586B
YoY Change 50.28% 28.21% 2.83%
LONG-TERM ASSETS
Property, Plant & Equipment $522.7M $487.4M $467.3M
YoY Change 9.41% 4.29% 10.01%
Goodwill $2.767B $1.939B $1.922B
YoY Change 41.8% 0.87% 1.17%
Intangibles
YoY Change
Long-Term Investments $64.10M $7.890M $15.77M
YoY Change 362.68% -49.96% -12.74%
Other Assets $260.2M $173.4M $163.0M
YoY Change 57.16% 6.4% 12.01%
Total Long-Term Assets $4.351B $3.144B $3.143B
YoY Change 36.5% 0.03% 2.1%
TOTAL ASSETS
Total Short-Term Assets $2.325B $2.034B $1.586B
Total Long-Term Assets $4.351B $3.144B $3.143B
Total Assets $6.676B $5.178B $4.729B
YoY Change 41.0% 9.48% 2.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $196.0M $181.5M $173.7M
YoY Change 19.98% 4.48% 47.71%
Accrued Expenses $312.2M $324.1M $274.1M
YoY Change 8.84% 18.22% 1.57%
Deferred Revenue $133.9M $108.2M $112.5M
YoY Change 19.94% -3.85% 10.28%
Short-Term Debt $9.900M $9.906M $12.00M
YoY Change -17.5% -17.45% 0.1%
Long-Term Debt Due $9.900M $9.906M $12.00M
YoY Change -17.5% -17.45% 0.0%
Total Short-Term Liabilities $732.7M $692.7M $624.2M
YoY Change 17.98% 10.97% 5.64%
LONG-TERM LIABILITIES
Long-Term Debt $1.791B $785.4M $793.7M
YoY Change 168.08% -1.04% -24.01%
Other Long-Term Liabilities $50.60M $5.838M $5.981M
YoY Change 696.9% -2.39% -30.19%
Total Long-Term Liabilities $2.205B $1.052B $1.079B
YoY Change 127.85% -2.5% -20.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $732.7M $692.7M $624.2M
Total Long-Term Liabilities $2.205B $1.052B $1.079B
Total Liabilities $2.938B $1.745B $1.703B
YoY Change 84.91% 2.44% -12.3%
SHAREHOLDERS EQUITY
Retained Earnings $3.920B $3.760B $3.222B
YoY Change 16.58% 16.69% 9.09%
Common Stock $1.711B $1.702B $1.644B
YoY Change 5.02% 3.54% 3.5%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B
YoY Change 0.0%
Treasury Stock Shares $41.84M
Shareholders Equity $3.738B $3.433B $3.026B
YoY Change
Total Liabilities & Shareholders Equity $6.676B $5.178B $4.729B
YoY Change 41.0% 9.48% 2.34%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $224.9M $210.5M $203.6M
YoY Change 11.48% 3.37% 14.15%
Depreciation, Depletion And Amortization $37.77M $36.27M $39.10M
YoY Change -7.41% -7.23% -0.92%
Cash From Operating Activities $128.6M $44.66M -$65.66M
YoY Change -41.5% -168.02% -145.6%
INVESTING ACTIVITIES
Capital Expenditures -$31.67M $29.06M $27.34M
YoY Change -20.21% 6.28% 102.5%
Acquisitions $19.10M $0.00
YoY Change
Other Investing Activities -$994.7M -$26.43M -$10.08M
YoY Change 2180.63% 162.21% 196.5%
Cash From Investing Activities -$1.026B -$58.81M -$41.87M
YoY Change 1132.07% 40.44% 89.39%
FINANCING ACTIVITIES
Cash Dividend Paid $64.43M $61.19M
YoY Change 5.3% 8.28%
Common Stock Issuance & Retirement, Net $4.354M
YoY Change 324.37%
Debt Paid & Issued, Net $30.00M $0.00
YoY Change -100.0%
Cash From Financing Activities 932.9M -$41.88M 92.97M
YoY Change -527.99% -145.05% -153.05%
NET CHANGE
Cash From Operating Activities 128.6M $44.66M -65.66M
Cash From Investing Activities -1.026B -$58.81M -41.87M
Cash From Financing Activities 932.9M -$41.88M 92.97M
Net Change In Cash 35.13M -$66.55M -19.13M
YoY Change -143.15% 247.89% -54.17%
FREE CASH FLOW
Cash From Operating Activities $128.6M $44.66M -$65.66M
Capital Expenditures -$31.67M $29.06M $27.34M
Free Cash Flow $160.3M $15.61M -$93.00M
YoY Change -38.24% -116.78% -171.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000943819
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-15317
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
ResMed Inc.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0152841
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
9001 Spectrum Center Blvd.
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92123
CY2022Q3 dei Entity Address Country
EntityAddressCountry
US
CY2022Q3 dei City Area Code
CityAreaCode
858
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
836-5000
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.004 per share
CY2022Q3 dei Trading Symbol
TradingSymbol
RMD
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146483650 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207163000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
273710000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23867000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23259000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
620483000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
575950000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
864852000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
743910000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
341199000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337908000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
2033697000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1931478000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
487376000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
498181000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125319000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
132314000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1938843000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
1936442000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
338151000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
345944000 usd
CY2022Q3 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
80745000 usd
CY2022Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
79746000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
173429000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
171748000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3143863000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3164375000 usd
CY2022Q3 us-gaap Assets
Assets
5177560000 usd
CY2022Q2 us-gaap Assets
Assets
5095853000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
181485000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
159245000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
324055000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
344722000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21076000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21856000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
108195000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
108667000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
47942000 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
44893000 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
9906000 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9916000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
692659000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
689299000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
97620000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
95455000 usd
CY2022Q3 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
11830000 usd
CY2022Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
9714000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
114214000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
120453000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5838000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5974000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
785436000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
765325000 usd
CY2022Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
37076000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2022Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
48882000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1052014000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1045803000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1744673000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1735102000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188295266 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146459032 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188246955 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146410721 shares
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
586000 usd
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
586000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1701902000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1682432000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3759783000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3613736000 usd
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41836234 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41836234 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3360751000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5177560000 usd
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1623256000 usd
CY2022Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1623256000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406128000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-312747000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3432887000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5095853000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
950294000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
904015000 usd
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
403110000 usd
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
386667000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6374000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11059000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
409484000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
397726000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
540810000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
506289000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
193933000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176719000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63188000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59950000 usd
CY2022Q3 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
7950000 usd
CY2021Q3 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
7707000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
265071000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
244376000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
275739000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
261913000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7134000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5360000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2028000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1386000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3280000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
5612000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1504000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1991000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13946000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3125000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
261793000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
258788000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51315000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55175000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
210478000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
203613000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.40
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.39
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146431000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145680000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147134000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146860000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
210478000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
203613000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-93381000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23516000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
117097000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
180097000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3360751000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2610000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-59000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16919000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-93381000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
210478000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2022Q3 us-gaap Dividends
Dividends
64431000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3432887000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2885679000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4354000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-195000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17303000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23516000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
203613000 usd
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2021Q3 us-gaap Dividends
Dividends
61189000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3026049000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
210478000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
203613000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36273000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39102000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
7761000 usd
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8517000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
16919000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
17303000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2028000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1386000 usd
CY2022Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-3280000 usd
CY2021Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
5612000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
56238000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33704000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
147096000 usd
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55976000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
36784000 usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14391000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8041000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-293303000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44662000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65657000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29056000 usd
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27340000 usd
CY2022Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3317000 usd
CY2021Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4453000 usd
CY2022Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19100000 usd
CY2021Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4291000 usd
CY2021Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6600000 usd
CY2022Q3 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
3042000 usd
CY2021Q3 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
3481000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58806000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41874000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2610000 usd
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4354000 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
59000 usd
CY2021Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
195000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
50000000 usd
CY2021Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
150000000 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
30000000 usd
CY2021Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
64431000 usd
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
61189000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41880000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92970000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10523000 usd
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4568000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66547000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19129000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273710000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295278000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
207163000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
276149000 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
53437000 usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
345909000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
7134000 usd
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
5360000 usd
CY2022Q3 rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
9506000 usd
CY2021Q3 rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
0 usd
CY2022Q3 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
3975000 usd
CY2021Q3 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 usd
CY2022Q3 rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
19281000 usd
CY2021Q3 rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
0 usd
CY2022Q3 rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
2856000 usd
CY2021Q3 rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
0 usd
CY2022Q3 rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
2856000 usd
CY2021Q3 rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
0 usd
CY2022Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
19100000 usd
CY2021Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
23700000 usd
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
25200000 usd
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
950294000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
904015000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36273000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39102000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
398520000 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
355225000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4491000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3077000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
461841000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
385608000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
864852000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
743910000 usd
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
92226000 usd
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
99352000 usd
CY2022Q3 rmd Prepaid Inventory
PrepaidInventory
122839000 usd
CY2022Q2 rmd Prepaid Inventory
PrepaidInventory
107291000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
126134000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
131265000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
341199000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337908000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1107564000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1131295000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
620188000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
633114000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
487376000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
498181000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
338151000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
345944000 usd
CY2022Q2 rmd Equity Investments
EquityInvestments
58375000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
1936442000 usd
CY2022Q3 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
19281000 usd
CY2022Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-16880000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
1938843000 usd
CY2022Q3 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
5887000 usd
CY2022Q2 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
9167000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
43581000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
39290000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
7890000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
9918000 usd
CY2022Q3 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
57358000 usd
CY2022Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
58375000 usd
CY2022Q3 rmd Additional Equity Investments
AdditionalEquityInvestments
4291000 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-3280000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2028000 usd
CY2022Q3 rmd Equity Investments
EquityInvestments
57358000 usd
CY2021Q2 rmd Equity Investments
EquityInvestments
69240000 usd
CY2021Q3 rmd Additional Equity Investments
AdditionalEquityInvestments
6600000 usd
CY2021Q3 rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
5367000 usd
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
454000 usd
CY2021Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
209000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1386000 usd
CY2021Q3 rmd Equity Investments
EquityInvestments
80066000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-3300000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
5600000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25889000 usd
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
22032000 usd
CY2022Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2088000 usd
CY2021Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5413000 usd
CY2022Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2612000 usd
CY2021Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3972000 usd
CY2022Q3 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-1272000 usd
CY2021Q3 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-513000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
24093000 usd
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
22960000 usd
CY2022Q3 rmd Short Term Debt Gross
ShortTermDebtGross
10000000 usd
CY2022Q2 rmd Short Term Debt Gross
ShortTermDebtGross
10000000 usd
CY2022Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
94000 usd
CY2022Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
84000 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
9906000 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9916000 usd
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
790000000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
770000000 usd
CY2022Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4564000 usd
CY2022Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4675000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
785436000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
765325000 usd
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
795342000 usd
CY2022Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
775241000 usd
CY2022Q3 rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
CY2022Q3 rmd Line Of Credit Facility Collateral Percentage Of Company
LineOfCreditFacilityCollateralPercentageOfCompany
0.10
CY2022Q3 us-gaap Senior Notes
SeniorNotes
500000000 usd
CY2022Q2 us-gaap Senior Notes
SeniorNotes
500000000 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
113167000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1322000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
210478000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
203613000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146431000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145680000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
703000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1180000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147134000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146860000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.40
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.39
CY2022Q3 rmd Receivables Sold With Limited Recourse
ReceivablesSoldWithLimitedRecourse
39900000 usd
CY2021Q3 rmd Receivables Sold With Limited Recourse
ReceivablesSoldWithLimitedRecourse
49500000 usd
CY2022Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
22400000 usd
CY2022Q3 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
1200000 usd
CY2022Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
24200000 usd
CY2022 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
2100000 usd
CY2022Q2 us-gaap Contractual Obligation
ContractualObligation
950000000 eur

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000943819-22-000019-index-headers.html Edgar Link pending
0000943819-22-000019-index.html Edgar Link pending
0000943819-22-000019.txt Edgar Link pending
0000943819-22-000019-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20220930.htm Edgar Link pending
rmd-20220930.xsd Edgar Link pending
rmd-20220930xex311.htm Edgar Link pending
rmd-20220930xex312.htm Edgar Link pending
rmd-20220930xex32.htm Edgar Link pending
Show.js Edgar Link pending
rmd-20220930_cal.xml Edgar Link unprocessable
rmd-20220930_def.xml Edgar Link unprocessable
rmd-20220930_pre.xml Edgar Link unprocessable
rmd-20220930_lab.xml Edgar Link unprocessable
rmd-20220930_htm.xml Edgar Link completed